TY - JOUR
T1 - Design, methods, and evaluation directions of a multi-access service for the management of diabetes mellitus patients
AU - Bellazzi, Riccardo
AU - De Cata, Pasquale
AU - De Leiva, Alberto
AU - Deutsch, Tibor
AU - Fratino, Pietro
AU - Gazzaruso, Carmine
AU - Garcìa, Angel
AU - Gergely, Tamás
AU - Gómez, Enrique
AU - Harvey, Fiona
AU - Ferrari, Pietro
AU - Arcelloni, Marco
AU - Hernando, Elena
AU - Boulos, Maged Kamel
AU - Larizza, Cristiana
AU - Ludekke, Hans
AU - Maran, Alberto
AU - Nucci, Gianluca
AU - Pennati, Cristina
AU - Ramat, Stefano
AU - Roudsari, Abdul
AU - Rigla, Mercedes
AU - Bensa, Giuliana
AU - Stefanelli, Mario
AU - Blankenfeld, Hannes
AU - Brugués, Eulàlia
AU - Carson, Ewart
AU - Cobelli, Claudio
AU - Cramp, Derek
AU - D'Annunzio, Giuseppe
N1 - © Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2003/7
Y1 - 2003/7
N2 - Recent advances in information and communication technology allow the design and testing of new models of diabetes management, which are able to provide assistance to patients regardless of their distance from the health care providers. The M2DM project, funded by the European Commission, has the specific aim to investigate the potential of novel telemedicine services in diabetes management. A multi-access system based on the integration of Web access, telephone access through interactive voice response systems, and the use of palmtops and smart modems for data downloading has been implemented. The system is based on a technological platform that allows a tight integration between the access modalities through a middle layer called the multi-access organizer. Particular attention has been devoted to the design of the evaluation scheme for the system: A randomized controlled study has been defined, with clinical, organizational, economic, usability, and users' satisfaction outcomes. The evaluation of the system started in January 2002. The system is currently used by 67 patients and seven health care providers in five medical centers across Europe. After 6 months of usage of the system no major technical problems have been encountered, and the majority of patients are using the Web and data downloading modalities with a satisfactory frequency. From a clinical viewpoint, the hemoglobin A1c (HbA1c) of both active patients and controls decreased, and the variance of HbA1c in active patients is significantly lower than the control ones. The M2DM system allows for the implementation of an easy-to-use, user-tailored telemedicine system for diabetes management. The first clinical results are encouraging and seem to substantiate the hypothesis of its clinical effectiveness.
AB - Recent advances in information and communication technology allow the design and testing of new models of diabetes management, which are able to provide assistance to patients regardless of their distance from the health care providers. The M2DM project, funded by the European Commission, has the specific aim to investigate the potential of novel telemedicine services in diabetes management. A multi-access system based on the integration of Web access, telephone access through interactive voice response systems, and the use of palmtops and smart modems for data downloading has been implemented. The system is based on a technological platform that allows a tight integration between the access modalities through a middle layer called the multi-access organizer. Particular attention has been devoted to the design of the evaluation scheme for the system: A randomized controlled study has been defined, with clinical, organizational, economic, usability, and users' satisfaction outcomes. The evaluation of the system started in January 2002. The system is currently used by 67 patients and seven health care providers in five medical centers across Europe. After 6 months of usage of the system no major technical problems have been encountered, and the majority of patients are using the Web and data downloading modalities with a satisfactory frequency. From a clinical viewpoint, the hemoglobin A1c (HbA1c) of both active patients and controls decreased, and the variance of HbA1c in active patients is significantly lower than the control ones. The M2DM system allows for the implementation of an easy-to-use, user-tailored telemedicine system for diabetes management. The first clinical results are encouraging and seem to substantiate the hypothesis of its clinical effectiveness.
KW - hemoglobin A1c
UR - http://www.scopus.com/inward/record.url?scp=10744228159&partnerID=8YFLogxK
U2 - 10.1089/152091503322250640
DO - 10.1089/152091503322250640
M3 - Article
C2 - 14511417
AN - SCOPUS:10744228159
SN - 1520-9156
VL - 5
SP - 621
EP - 629
JO - Diabetes Technology and Therapeutics
JF - Diabetes Technology and Therapeutics
IS - 4
ER -